StockGuru Blog: The Immune Response Vaccines — Clinical Trials for HIV Infections
IMNR - The Immune Response Corporation Clinical Studies With IR 103 IMNR’s clinical trial program is testing IR103 in drug-naïve…
Blog
StockGuru News: IncreMental Advantage Initiates Coverage of The Immune Response Corporation with Price Target of $0.09 Per Share, Accumulate Rating
IncreMental Advantage Initiates Coverage of The Immune Response Corporation with Price Target of $0.09 Per Share, Accumulate Rating The Immune…
StockGuru News: Response Biomedical Corporation, China Wireless Communications, Cavico Corporation, Oxford Media, and Enterayon
Response Biomedical Corp. (OTCBB: RPBIF) & (TSX.V: RBM) Response Biomedical Completes US Distribution Network For RAMP Cardiovascular Products US Distributors…
StockGuru Blog: The Immune Response Vaccines — How They Work: Fight an Existing Disease Rather than Prevent Disease
IMNR - The Immune Response Corporation Immune Response Vaccines: The Immune Response vaccines differ from the conventional vaccines in that…
Elgrande International, Inc. has a Winning Team in Place
EGDI – Elgrande International, Inc.Elgrande International (OTCBB: EGDI) has a winning team in place. Michael F. Holloran - President and…
StockGuru Welcomes The Immune Response Corporation (OTCBB: IMNR)
StockGuru Welcomes The Immune Response Corporation (OTCBB: IMNR) View the StockGuru Profile for The Immune Response Corporation: http://www.stockguru.com/profiles/imnr/ The Immune…
StockGuru Blog: IncreMental Advantage Initiates Coverage of The Immune Response Corporation – Price Target of $0.09 Per Share Accumulate Rating
IMNR - The Immune Response Corporation IncreMental Advantage, an equity research firm, has initiated coverage of The Immune Response Corporation…
StockGuru Blog: THE IMMUNE RESPONSE CORPORATION If You’ve Overlooked our Recent Releases Rely on Our Remedy – A Reliable Review!
IMNR - The Immune Response CorporationThe Immune Response Corporation was founded in 1986 by Dr. Jonas Salk, the developer of…
July 24th CEOcast Weekly Newsletter
07/23/2006 VOLUME 248 Companies featured in the current edition of the newsletter: ADSX, ASPN, CDGT, CPPT, EMIS, ENZ, FLWE, FSN,…
StockGuru Blog: The Immune Response Corporation – Multiple Sclerosis Important Advancements Phase IIb Clinical Trials Scheduled
IMNR - The Immune Response CorporationImportant Phase IIb Trials Set to Begin for MS Treatment - NeuroVax NeuroVax Phase IIb…